| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jan 22, 2013
The Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg...
-
Jan 18, 2013
Perrigo Company (Nasdaq: PRGO;TASE:) today announced that it will release financial results for its second quarter fiscal year 2013 on Friday,...
-
Jan 15, 2013
Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has begun commercial shipments of betamethasone valerate foam 0.12%, the generic...
-
Jan 7, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has made initial shipments distributing Cumberland Pharmaceuticals Inc.'s ("Cumberland")...
-
Jan 7, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced that its infant formula division has gained FDA clearance to manufacture three new infant formula...
-
Jan 2, 2013
Perrigo Company (Nasdaq: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the J.P. Morgan 31st...
-
Dec 28, 2012-- Solidifies Perrigo's leadership position in topical foam-based generic prescription pharmaceuticals
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has signed a definitive merger agreement and has completed the acquisition of Cobrek...
-
Dec 4, 2012
The Perrigo Company (Nasdaq: PRGO;TASE) today announced the appointment of Douglas Boothe as Executive Vice President and General Manager, Perrigo...
-
Nov 28, 2012
Perrigo Company (Nasdaq: PRGO; TASE) today announced that it has agreed to settle its Hatch-Waxman litigation relating to Ofirmev® (acetaminophen)...
-
Nov 27, 2012
Perrigo Company (Nasdaq: PRGO;TASE) today announced that its partner, Cobrek Pharmaceuticals, Inc., received final approval from the U.S. Food and...